|4Oct 30, 4:12 PM ET

Dunn Gordon 4

4 · Quoin Pharmaceuticals, Ltd. · Filed Oct 30, 2023

Insider Transaction Report

Form 4
Period: 2023-10-26
Dunn Gordon
Chief Financial Officer
Transactions
  • Award

    Share Option (Right to Buy)

    2023-10-26+51,14951,149 total
    Exercise: $5.75From: 2024-10-26Exp: 2033-10-26American Depositary Share (51,149 underlying)
Footnotes (2)
  • [F1]The number of securities underlying the option and the exercise price are listed in terms of American Depositary Shares ("ADSs"), with sixty thousand (60,000) ordinary shares of the Issuer represented by one (1) ADS.
  • [F2]The option vests in four annual installments with 20% vesting on each of October 26, 2024, 2025 and 2026 and 40% vesting on October 26, 2027.

Documents

1 file
  • 4
    tm2329341-4_4seq1.xmlPrimary

    OWNERSHIP DOCUMENT